Symbol="CKPT"
AssetType="Common Stock"
Name="Checkpoint Therapeutics Inc"
Description="Checkpoint Therapeutics, Inc., a clinical-stage immuno-oncology biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company is headquartered in New York, New York."
CIK="1651407"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="44050700"
EBITDA="None"
PERatio="None"
PEGRatio="0"
BookValue="-1.297"
DividendPerShare="0"
DividendYield="0"
EPS="-5.1"
RevenuePerShareTTM="0.01"
ProfitMargin="0"
OperatingMarginTTM="-327.59"
ReturnOnAssetsTTM="-1.905"
ReturnOnEquityTTM="-12.2"
RevenueTTM="188000"
GrossProfitTTM="-48185000"
DilutedEPSTTM="-5.1"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.722"
AnalystTargetPrice="23.4"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="277.67"
PriceToBookRatio="8.56"
EVToRevenue="105.41"
EVToEBITDA="-0.198"
Beta="1.443"
num_52WeekHigh="14.1"
num_52WeekLow="1.84"
num_50DayMovingAverage="2.556"
num_200DayMovingAverage="3.926"
SharesOutstanding="20893500"
DividendDate="None"
ExDividendDate="None"
symbol="CKPT"
open="2.05"
high="2.09"
low="2.00"
price="2.04"
volume="162402.00"
latest_trading_day="2023-08-25"
previous_close="2.05"
change="-0.01"
change_percent="-0.4878%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="85"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="15"
Volume_recent_avg="265296"
Change_recent_avg="-0.01"
Delta_recent_avg="0.25"
Variance_recent_avg="0.12"
Change_ratio_recent_avg="-0.64"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="15"
Aroon_momentum_negative="85"
image_negative_thumbnail_id_1="153"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0023.jpeg"
image_negative_thumbnail_id_2="1095"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0128.jpeg"
image_neutral_thumbnail_id_1="591"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0008.jpeg"
image_neutral_thumbnail_id_2="570"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0029.jpeg"
image_positive_thumbnail_id_1="607"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0101.jpeg"
image_positive_thumbnail_id_2="695"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0013.jpeg"
image_professor_thumbnail_id_1="1202"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0036.jpeg"
image_professor_thumbnail_id_2="1185"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
